Cardiovascular diseases (CVDs) are the number one cause of death worldwide, taking 17.9
million lives each year. The rapid, sensitive, and accurate determination of cardiac …

Myocardial ischemia-reperfusion injury (IRI) is becoming a typical cardiovascular disease
with increasing worldwide incidence. It is usually induced by the restoration of normal blood …

Wearable technologies for personalized monitoring require sensors that track biomarkers
often present at low levels. Cortisol—a key stress biomarker—is present in sweat at low …

Noble-metal nanozymes have demonstrated great potential in various fields. However,
aggregation of single-particle nanoparticles severely affects their exposed catalytically …

Considering the fact that acute myocardial infarction has shown a trend towards younger
age and has become a major health problem, it is necessary to develop rapid screening …

Nanoribbon-and nanowire-based field-effect transistor (FET) biosensors have stimulated a
lot of interest. However, most FET biosensors were achieved by using bulky Ag/AgCl …

Early cancer diagnosis and treatment are crucial research fields of human health. One
method that has proven efficient is biomarker detection which can provide real-time and …

Sensitive detection of cardiac biomarkers is critical for clinical diagnostics of myocardial
infarction (MI) while such detection is quite challenging due to the ultra-low concentration of …

Myocardial infarction (MI) is a cardiovascular emergency and the leading cause of death
worldwide. Inflammatory and immune responses are initiated immediately after MI, leading …

To develop a robust method for the detection of disease biomarkers is always the pursued
goal in the field of biomedical research. Multi-modal immunoassay strategy will bring …